CN111454150B - Synthesis method of (S) -2-aryl propionate compound - Google Patents
Synthesis method of (S) -2-aryl propionate compound Download PDFInfo
- Publication number
- CN111454150B CN111454150B CN202010190577.9A CN202010190577A CN111454150B CN 111454150 B CN111454150 B CN 111454150B CN 202010190577 A CN202010190577 A CN 202010190577A CN 111454150 B CN111454150 B CN 111454150B
- Authority
- CN
- China
- Prior art keywords
- carbon atoms
- nickel
- formula
- substituted
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001308 synthesis method Methods 0.000 title claims abstract description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000011941 photocatalyst Substances 0.000 claims abstract description 27
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000003446 ligand Substances 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000003638 chemical reducing agent Substances 0.000 claims abstract description 13
- 239000003513 alkali Substances 0.000 claims abstract description 10
- -1 diethylene glycol dimethyl ether compound Chemical class 0.000 claims description 56
- 238000006243 chemical reaction Methods 0.000 claims description 52
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims description 29
- 229910052759 nickel Inorganic materials 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- PRWATGACIORDEL-UHFFFAOYSA-N 2,4,5,6-tetra(carbazol-9-yl)benzene-1,3-dicarbonitrile Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=C(C#N)C(N2C3=CC=CC=C3C3=CC=CC=C32)=C(N2C3=CC=CC=C3C3=CC=CC=C32)C(N2C3=CC=CC=C3C3=CC=CC=C32)=C1C#N PRWATGACIORDEL-UHFFFAOYSA-N 0.000 claims description 16
- 229910052741 iridium Inorganic materials 0.000 claims description 15
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 13
- GSCCALZHGUWNJW-UHFFFAOYSA-N N-Cyclohexyl-N-methylcyclohexanamine Chemical compound C1CCCCC1N(C)C1CCCCC1 GSCCALZHGUWNJW-UHFFFAOYSA-N 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- LJXTYJXBORAIHX-UHFFFAOYSA-N diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1 LJXTYJXBORAIHX-UHFFFAOYSA-N 0.000 claims description 12
- JRTIUDXYIUKIIE-KZUMESAESA-N (1z,5z)-cycloocta-1,5-diene;nickel Chemical compound [Ni].C\1C\C=C/CC\C=C/1.C\1C\C=C/CC\C=C/1 JRTIUDXYIUKIIE-KZUMESAESA-N 0.000 claims description 11
- DIIWSYPKAJVXBV-UHFFFAOYSA-N Hantzch dihydropyridine Natural products CCOC(=O)C1=CC(C(=O)OCC)=C(C)N=C1C DIIWSYPKAJVXBV-UHFFFAOYSA-N 0.000 claims description 11
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- 125000001624 naphthyl group Chemical class 0.000 claims description 6
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 3
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- WSWDAKKWVAVVAI-UHFFFAOYSA-N ditert-butyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CC1=C(C(=O)OC(C)(C)C)CC(C(=O)OC(C)(C)C)=C(C)N1 WSWDAKKWVAVVAI-UHFFFAOYSA-N 0.000 claims description 3
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims description 3
- ZBRJXVVKPBZPAN-UHFFFAOYSA-L nickel(2+);triphenylphosphane;dichloride Chemical compound [Cl-].[Cl-].[Ni+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 ZBRJXVVKPBZPAN-UHFFFAOYSA-L 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 2
- VEEMVPAUPIJPLA-UHFFFAOYSA-N 2-pyrazin-2-ylpyrazine ruthenium Chemical compound [Ru].c1cnc(cn1)-c1cnccn1.c1cnc(cn1)-c1cnccn1.c1cnc(cn1)-c1cnccn1 VEEMVPAUPIJPLA-UHFFFAOYSA-N 0.000 claims description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 claims description 2
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- TXNLQUKVUJITMX-UHFFFAOYSA-N 4-tert-butyl-2-(4-tert-butylpyridin-2-yl)pyridine Chemical compound CC(C)(C)C1=CC=NC(C=2N=CC=C(C=2)C(C)(C)C)=C1 TXNLQUKVUJITMX-UHFFFAOYSA-N 0.000 claims description 2
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 claims description 2
- DRZUOPCJWAJOAG-UHFFFAOYSA-N CC(=O)C.CC(=O)C.[Ni] Chemical compound CC(=O)C.CC(=O)C.[Ni] DRZUOPCJWAJOAG-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 2
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- FKDYIXOYTANTSV-UHFFFAOYSA-N dimethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1 FKDYIXOYTANTSV-UHFFFAOYSA-N 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 claims description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 2
- UQPSGBZICXWIAG-UHFFFAOYSA-L nickel(2+);dibromide;trihydrate Chemical compound O.O.O.Br[Ni]Br UQPSGBZICXWIAG-UHFFFAOYSA-L 0.000 claims description 2
- BFSQJYRFLQUZKX-UHFFFAOYSA-L nickel(ii) iodide Chemical compound I[Ni]I BFSQJYRFLQUZKX-UHFFFAOYSA-L 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 claims description 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- IPLJNQFXJUCRNH-UHFFFAOYSA-L nickel(2+);dibromide Chemical compound [Ni+2].[Br-].[Br-] IPLJNQFXJUCRNH-UHFFFAOYSA-L 0.000 claims 3
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 claims 2
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims 1
- 229910021585 Nickel(II) bromide Inorganic materials 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 63
- 238000001228 spectrum Methods 0.000 description 49
- 239000000047 product Substances 0.000 description 44
- 239000007787 solid Substances 0.000 description 31
- 239000006227 byproduct Substances 0.000 description 29
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 24
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 24
- 229910052799 carbon Inorganic materials 0.000 description 24
- 229910052739 hydrogen Inorganic materials 0.000 description 24
- 239000001257 hydrogen Substances 0.000 description 24
- 238000005481 NMR spectroscopy Methods 0.000 description 15
- 239000003208 petroleum Substances 0.000 description 15
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 12
- 239000012043 crude product Substances 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 7
- GAWAYYRQGQZKCR-UHFFFAOYSA-N 2-chloropropionic acid Chemical compound CC(Cl)C(O)=O GAWAYYRQGQZKCR-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000027756 respiratory electron transport chain Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical group CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001699 photocatalysis Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 2
- 238000011914 asymmetric synthesis Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- QVQGTNFYPJQJNM-UHFFFAOYSA-N dicyclohexylmethanamine Chemical compound C1CCCCC1C(N)C1CCCCC1 QVQGTNFYPJQJNM-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SYSZENVIJHPFNL-UHFFFAOYSA-N (alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform B (protein) Chemical compound COC1=CC=C(I)C=C1 SYSZENVIJHPFNL-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- RTUDBROGOZBBIC-UHFFFAOYSA-N 1-iodo-4-(trifluoromethoxy)benzene Chemical compound FC(F)(F)OC1=CC=C(I)C=C1 RTUDBROGOZBBIC-UHFFFAOYSA-N 0.000 description 1
- UDHAWRUAECEBHC-UHFFFAOYSA-N 1-iodo-4-methylbenzene Chemical compound CC1=CC=C(I)C=C1 UDHAWRUAECEBHC-UHFFFAOYSA-N 0.000 description 1
- WQVIVQDHNKQWTM-UHFFFAOYSA-N 1-tert-butyl-4-iodobenzene Chemical compound CC(C)(C)C1=CC=C(I)C=C1 WQVIVQDHNKQWTM-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000013501 data transformation Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- RRSIMIHTHWYRRA-UHFFFAOYSA-L dibromonickel;1-methoxy-2-(2-methoxyethoxy)ethane Chemical compound Br[Ni]Br.COCCOCCOC RRSIMIHTHWYRRA-UHFFFAOYSA-L 0.000 description 1
- OCMNCWNTDDVHFK-UHFFFAOYSA-L dichloronickel;1,2-dimethoxyethane Chemical compound Cl[Ni]Cl.COCCOC OCMNCWNTDDVHFK-UHFFFAOYSA-L 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- UEEXRMUCXBPYOV-UHFFFAOYSA-N iridium;2-phenylpyridine Chemical compound [Ir].C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1 UEEXRMUCXBPYOV-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- FECKGFOXYFBBDR-UHFFFAOYSA-N n-cyclohexyl-n-methylcyclohexanamine;hydrochloride Chemical compound Cl.C1CCCCC1N(C)C1CCCCC1 FECKGFOXYFBBDR-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000711 polarimetry Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B37/00—Reactions without formation or introduction of functional groups containing hetero atoms, involving either the formation of a carbon-to-carbon bond between two carbon atoms not directly linked already or the disconnection of two directly linked carbon atoms
- C07B37/04—Substitution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/10—Formation of amino groups in compounds containing carboxyl groups with simultaneously increasing the number of carbon atoms in the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
The invention discloses a synthesis method of (S) -2-aryl propionate compounds, which comprises the steps of reacting a compound shown in a formula I and a compound shown in a formula II serving as raw materials under the condition of visible light with a chiral ligand shown in a formula III, a nickel catalyst, a photocatalyst, a reducing agent and alkali to obtain the (S) -2-aryl propionate compounds shown in a formula IV. The method has the advantages of cheap and easily-obtained raw materials, convenient generation, mild conditions, environmental protection and safety, wherein the photocatalyst can be recycled, the production cost is greatly reduced, meanwhile, the test operation is simple, the generated waste is less, and the method can be developed into an industrial production method.
Description
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a synthesis method of (S) -2-aryl propionate compounds.
Background
The 2-aryl propionic acid compounds are widely used non-steroidal anti-inflammatory drugs and have excellent antipyretic, anti-inflammatory and analgesic effects. The 2-methyl acetic acid side chain of the anti-inflammatory drug has stronger activity and less side effect than that of the (R) -configuration when the side chain exists in the (S) -configuration. Thus, countries around the world are increasingly inclined to use a single chiral isomer. There are three current methods for obtaining a single chiral pure compound: resolution, chiral source approach and asymmetric synthesis. Both of the first two methods have certain disadvantages, which in turn limits their industrial applications. For example, the first method wastes one-half of the isomer, and the second method uses rare chiral natural compound starting materials. In recent decades, the invention and application of asymmetric catalysis provide new ideas and methods for synthesizing 2-aryl propionic acid compounds with single configuration.
The target product similar compounds in the invention have been reported, and specific examples are as follows:
1. according to the document x.dai, n.a.strotman, g.c.fu, j.am.chem.soc.2008,130,3302-3303, the reaction scheme is as follows:
the method takes alpha-bromo-carboxylic ester and aryl silicon reagent as raw materials, and the (S) -2-aryl propionate compound is obtained by reaction in the presence of a catalyst nickel and a chiral nitrogen ligand. This reaction requires an aryl silicon reagent as a raw material, which is difficult to prepare and difficult to store for a long time.
2. The reaction scheme is as follows according to the documents Z.Huang, Z.Liu, S.Zhou Jianrong, JAm ChemSec 2011,133, 15882-15885:
the method takes silicon-based ketone acetal and aryl trifluoromethanesulfonate as raw materials, and the (S) -2-aryl propionate compounds are obtained through reaction in the presence of a palladium catalyst and an axial chiral phosphorus ligand. The raw materials of the reaction need to be synthesized in advance, so that the reaction cost is increased.
3. According to the documents J.Mao, F.Liu, M.Wang, L.Wu, B.Zheng, S.Liu, J.Zhong, Q.Bian, P.J.Walsh, J.am.chem.Soc.2014,136,17662-17668, the reaction scheme is as follows:
the method takes alpha-bromo-carboxylic ester and aryl-format reagent as raw materials, and the (S) -2-aryl propionate compound is obtained by reaction in the presence of a cobalt catalyst and a bisoxazolin chiral ligand. The reaction needs an aryl-formatted reagent which is extremely sensitive to air and water as a raw material, so that the reaction risk is increased, the reaction is carried out at the temperature of 80 ℃ below zero, the conditions are harsh, and the method is not suitable for industrial application.
4. According to the documents m.jin, l.adak, m.nakamura, j.am.chem.soc.2015,137,7128-7134, the reaction scheme is as follows:
the method takes alpha-chloro carboxylic ester and aryl format reagent as raw materials, and the (S) -2-aryl propionic ester compound is obtained by reaction in the presence of an iron catalyst and a chiral phosphorus ligand. The reaction requires aryl-formatted reagents which are extremely sensitive to air and water as raw materials, so that the reaction risk is increased.
Therefore, the novel catalytic system is developed to realize the asymmetric synthesis of the 2-aryl propionic acid ester compound to replace the prior synthesis process, and the method has important significance for realizing the industrial production of the (S) -2-aryl propionic acid compound and the derivative thereof.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a synthesis method of (S) -2-aryl propionate compounds, which does not need to use organic metal reagents with harsh conditions and has the advantages of cheap and easily obtained raw materials, simple operation and convenient production.
The reaction mechanism of the present invention is as follows:
HEH = reducing agent (e.g. 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylic acid diethyl ester)
4CzIPN = photocatalyst (e.g. 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile)
SET = single electron transfer
Ln = BiOX = chiral oxazolin ligand
Firstly, the zero-valent nickel Ni (0) and iodobenzene are oxidized and added to generate a divalent nickel complex
The other molecule of zero-valent nickel Ni (0) can change chloro-ester into a free radical intermediate through single electron transferAnd chloride anions, while zero-valent nickel is oxidized to monovalent nickel Ni (I);
free radical intermediatesCan be combined with divalent nickel complexes->Trapping to form trivalent nickel complexTrivalent nickel complex in the conjunction or in the absence of trivalent nickel complexes>The product is obtained after reduction and elimination>And monovalent nickel Ni (I);
the monovalent Ni (I) can be reacted with a photocatalyst 4CzIPN for obtaining an electron ·- Single electron transfer occurs to generate zero-valent nickel Ni (0) and photocatalyst, and then the next cycle is carried out.
Obtaining a photocatalyst 4CzIPN of an electron ·- Is obtained by single electron transfer of a reducing agent and a photocatalyst 4CzIPN which reaches an excited state under blue light irradiation.
Free radical intermediatesOr a photocatalyst 4CzIPN which can obtain an electron ·- And single electron transfer with chloro ester (grey path in the mechanism diagram).
The invention specifically adopts the following scheme:
a synthesis method of (S) -2-aryl propionate compounds comprises the following steps of reacting a compound shown in a formula I and a compound shown in a formula II serving as raw materials under the condition of 400-500nm of visible light with a chiral ligand shown in a formula III, a nickel catalyst, a photocatalyst, a reducing agent and alkali to obtain (S) -2-aryl propionate compounds shown in a formula IV:
the photocatalyst is selected from one or more of transition metal-containing iridium or ruthenium complex photocatalyst and non-metal organic photocatalyst;
the reducing agent is selected from one or more of dihydropyridine reducing agents or tertiary amine reducing agents;
the alkali is selected from one or more of carbonate inorganic alkali or tertiary amine organic alkali;
R 1 any substituent selected from the group consisting of branched and straight-chain alkyl groups having 1 to 10 carbon atoms, alkyl groups having 1 to 10 carbon atoms and containing ether bonds, cycloalkyl groups having 3 to 6 carbon atoms, benzyl, perbenzyl, 4-substituted benzyl, and 4-substituted benzyl is selected from the group consisting of trifluoromethyl, halogen, and alkoxy groups having 1 to 10 carbon atoms;
R 2 optionally selected from branched and linear alkyl groups of 1 to 10 carbon atoms, benzyl;
ar is optionally selected from phenyl, mono-or poly-substituted phenyl, naphthyl, substituted naphthyl, pyridyl, substituted pyridyl, indolyl, N-substituted indolyl, benzofuranyl, fluorene, thienyl;
the substituent in the 'mono-substituted or multi-substituted phenyl' is selected from branched and straight-chain alkyl with 1 to 10 carbon atoms, N-dimethylamino, alkoxy with 1 to 10 carbon atoms, trifluoromethoxy, halogen, trifluoromethyl, acetyl, ester group, cyano, boroester group, phenol group, phenyl and pyrrole group;
the substituents in "substituted pyridyl" are selected from halo;
the substituent in the N-substituted indolyl is selected from alkyl with 1-10 carbon atoms;
the substituents in the "substituted naphthyl" are selected from alkoxy groups of 1 to 10 carbon atoms.
Preferably, the photocatalytic agent is selected from tris (2, 2 '-bipyrazinyl) ruthenium di (hydrochloride), tris (4, 4' -di-tert-butyl-2, 2 '-bipyridyl) bis [ (2-pyridyl) phenyl ] iridium (III) hexafluorophosphate, tris (2-phenylpyridine) iridium, (2, 2' -bipyridyl) bis [2- (4-fluorophenyl) pyridine ] iridium (III) hexafluorophosphate, 10-methyl-9-mesityleneacridine perchlorate or 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile; and/or
The reducing agent is selected from diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate, di-tert-butyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate, dimethyl 1, 4-dihydro-2, 6-dimethylpyridine-3, 5-dicarboxylate, N-dicyclohexylmethylamine, triethylamine, N-diisopropylethylamine; and/or
The alkali is selected from N, N-dicyclohexyl methylamine, triethylamine, N-diisopropyl ethylamine, cesium carbonate, sodium carbonate, lithium carbonate and potassium carbonate.
Preferably, R in the formula I 1 Selected from branched or straight chain alkyl with 1-4 carbon atoms, alkyl with 1-4 carbon atoms containing ether bond, cycloalkyl with 3-6 carbon atoms, benzyl, high benzyl or 4-substituted benzyl, wherein the substituent in the 4-substituted benzyl is selected from trifluoromethyl, halogen and alkoxy with 1-3 carbon atoms; and/or
R in the formula I 2 Optionally selected from branched and straight chain alkyl of 1 to 7 carbon atoms, benzyl; and/or
Ar in the formula II is selected from phenyl, 4-methylphenyl, 4-tert-butylphenyl, 4-N, N-dimethylphenyl, 4-methoxyphenyl, 4-trifluoromethoxyphenyl, 4-fluorophenyl, 4-chlorophenyl, acetylphenyl, 4-ethoxycarbonylphenyl, 4-cyanophenyl, 4-borocarbonylphenyl, 3-methylphenyl, 3-phenylphenyl, 3-chlorophenyl, 2-methylphenyl, 4-biphenyl, 3-fluoro-4-biphenyl, 4-pyrrolylphenyl, 2-9H-fluorenyl, 2-6-methoxynaphthyl, 1-naphthyl, 5-N-methylindolyl, 5-2-fluoropyridyl, 3-thienyl, 3-benzofuranyl.
Preferably, the nickel-based catalyst is selected from one or more of nickel chloride, nickel bromide, nickel iodide, bis- (1, 5-cyclooctadiene) nickel, nickel (II) bromide-diethylene glycol dimethyl ether complex, nickel diacetone, bis (triphenylphosphine) nickel chloride, (1, 1' -bis (diphenylphosphino) ferrocene) nickel dichloride or nickel chloride-dimethoxyethane complex.
Preferably, the reaction is carried out in a solvent selected from any one or more of dimethyl sulfoxide, N-dimethylformamide, N-dimethylacetamide and acetonitrile.
Preferably, the molar ratio of the compound shown in the formula I to the compound shown in the formula II, the nickel-based catalyst, the chiral ligand shown in the formula III, the photocatalyst, the reducing agent and the base is 1: (1-5): (0.01-1): (0.01-1): (0.01-1): (1-5): (1-5).
Preferably, the molar ratio of the compound shown in the formula I to the compound shown in the formula II, the nickel-based catalyst, the chiral ligand shown in the formula III, the photocatalyst, the reducing agent and the base is 1:3:0.1:0.11:0.1:3:3.
preferably, the reaction is carried out under blue light with a wavelength of 400 nm.
Preferably, the reaction temperature is 10 to 50 ℃.
The synthesis method according to claim 1, characterized in that the reaction is carried out in an inert gas or nitrogen atmosphere. The higher benzyl group in the synthesis method means phenylethyl group, and the alkyl group of 1 to 10 carbon atoms containing ether bond means that ether bond is contained in branched or straight chain alkyl group, such as 3-methoxypropyl group.
Advantageous effects
The technical scheme of the invention can at least achieve one of the following beneficial effects:
the method has the advantages of cheap and easily obtained raw materials, convenient generation, mild conditions, environmental protection, safety and the like;
the photocatalyst can be recycled, so that the production cost is greatly reduced;
the invention has simple test operation and less waste generation, and can be developed into an industrial production method;
all raw materials or catalysts used in the method can be dissolved in a solvent, the reaction can be a homogeneous reaction, and the method is more convenient for production and more suitable for industrial production;
the reaction of the invention is green chemistry, and all other byproducts except hydrochloric acid and hydroiodic acid have useful value. The photocatalyst can be recycled, as shown in the following, the by-product 1 and the by-product 2 obtained by the reaction are both valuable by-products, the by-product 1 is a pyridine compound and is one of chemical raw materials, the by-product 2 is dicyclohexyl methylamine hydrochloride or hydroiodide, and dicyclohexyl methylamine can be obtained by alkalization.
The invention carries out screening optimization on the synthesis conditions, such as reaction solvent, used alkali, catalyst, reaction temperature and time, and the like, and further improves the reaction yield and ee value.
Drawings
Embodiments of the present invention will be described in detail with reference to the accompanying drawings, in which
FIG. 1 example 1 Hydrogen spectrum of target product
FIG. 2 carbon spectrum of target product in example 1
FIG. 3 Hydrogen spectrum of by-product 1 in example 1
FIG. 4 carbon spectrum of by-product 1 of example 1
FIG. 5 Hydrogen spectrum of by-product 2 of example 1
FIG. 6 carbon spectrum of by-product 2 of example 1
FIG. 7 hydrogen spectrum of recovered photocatalytic reagent of example 1
FIG. 8 carbon spectrum of recovered photocatalytic reagent of example 1
FIG. 9 example 2 hydrogen spectrum of target product
FIG. 10 carbon spectrum of target product in example 2
FIG. 11 example 3 Hydrogen Spectrum of target product
FIG. 12 carbon spectrum of target product in example 3
FIG. 13 example 4 Hydrogen Spectroscopy of target product
FIG. 14 carbon spectrum of target product in example 4
FIG. 15 hydrogen spectrum of target product in example 5
FIG. 16 carbon spectrum of target product in example 5
FIG. 17 example 6 Hydrogen Spectrum of target product
FIG. 18 carbon spectrum of target product in example 6
FIG. 19 example 19 target product hydrogen spectrum
FIG. 20 carbon spectrum of target product in example 19
FIG. 21 example 23 Hydrogen Spectrum of target product
FIG. 22 example 23 carbon spectrum of target product
FIG. 23 example 26 Hydrogen Spectrum of target product
FIG. 24 carbon spectrum of target product in example 26
FIG. 25 example 42 target product Hydrogen Spectrum
FIG. 26 example 42 carbon spectrum of target product
Detailed Description
The invention is further illustrated by the following examples, which are intended to be illustrative and not limiting. It will be understood by those of ordinary skill in the art that these examples are not intended to limit the present invention in any way and that suitable modifications and data transformations may be made without departing from the spirit and scope of the present invention.
In the examples, NMR spectra 1 H-NMR and 13 C-NMR was measured using a 400MHz NMR spectrometer from Bruker, deuterated DMSO (DMSO-d) 6 ) Deuterated chloroform (CDCl) 3 ) The specific polarimetry was measured using polarimeter Autopol III polarimeter from luddov usa.
The raw materials used in the following examples were all purchased from the market.
The following reactions were all carried out under irradiation with blue light having a wavelength of 400 to 500 nm.
Example 1
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by iodobenzene (61.2mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6 mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (75.9mg, 0.3mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in this order. Covering the reaction bottleThe reaction mixture was sealed, taken out of the glove box, and placed on a stirrer irradiated with blue light having a wavelength of 400nm at room temperature and 25 ℃ for 48 hours. After the reaction, 10mL of ethyl acetate was added to the reaction solution, a solid precipitated, and the hydrogen spectrum and the carbon spectrum of the by-product 2 (white solid, 66% yield) obtained by filtration were shown in fig. 5 and 6, respectively, and the nmr spectrum data were shown in fig. 5 and 6, respectively: 1 H NMR(400MHz,DMSO-d 6 )δ:8.54(br,1H),3,30-3.23(m,2H),2.61-2.60(m,3H),1.95-1.92(m,4H),1.77-1.74(m,4H),1.58-1.55(m,2H),1.45-1.11(m,8H),1.08-1.01(m,2H).; 13 C{ 1 H}NMR(101MHz,DMSO-d 6 ) Delta 61.6,32.6,28.5,26.6,25.12,25.05,24.8. The filtrate was then washed with saturated brine (5mL × 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to give the crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate = 100) to give the target product represented by formula IV (oily liquid, 19.1mg,77% yield, 90% enantiomeric excess percentage, specific optical rotation [ α] D 20 =+22.41(c=0.424,CHCl 3 ) The value of the specific shift R f =0.54 (petroleum ether: ethyl acetate =50 = 1)), byproduct 1 and photocatalyst, the hydrogen spectrum and carbon spectrum of the target product are respectively shown in fig. 1 and fig. 2, and the nuclear magnetic resonance spectrum data are respectively shown in fig. 1: 1 H NMR(400MHz,CDCl 3 )δ:7.32-7.19(m,5H),3.62(q,J=7.2Hz,1H),1.47–1.46(m,6H),1.38(s,3H),0.82(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 ) Delta 173.8,141.4,128.6,127.6,126.9,87.2,47.1,38.4,25.1,20.6,20.3,18.2. The hydrogen and carbon spectra of byproduct 1 (white solid, 100% yield) are shown in fig. 3 and 4, respectively, and the nmr spectra data are: 1 H NMR(400MHz,CDCl 3 )δ:8.62(s,1H),4.34(q,J=7.1Hz,4H),2.79(s,6H),1.37(t,J=7.1Hz,6H). 13 C{ 1 H}NMR(101MHz,CDCl 3 ) 166.0,162.3,141.0,123.1,61.5,25.0,14.3, the hydrogen and carbon spectra of the recovered photocatalyst (yellow solid, 96% yield, reusable) are respectively shown in FIG. 7 and FIG. 8, and the data of nuclear magnetic resonance spectrum are respectively shown in FIG. 7: 1 H NMR(400MHz,CDCl 3 )δ:8.24–8.18(m,2H),7.75-7.64(m,8H),7.52–7.44(m,2H),7.32(d,J=7.7Hz,2H),7.23-7.18(m,4H),7.13–7.04(m,8H),6.87–6.78(m,4H),6.68–6.58(m,2H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:145.3,144.7,140.0,138.3,137.0,134.8,127.1,125.9,125.1,124.9,124.6,123.9,122.5,122.1,121.5,121.1,120.5,119.8,116.4,111.8,111.0,110.1,109.6,109.5。
example 2
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by 4-methyliodobenzene (65.4mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (75.9mg, 0.3mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in this order. The reaction bottle cap is covered and sealed, the glove box is taken out and placed on a stirrer irradiated by blue light, and the reaction is carried out for 48 hours at room temperature of 25 ℃. After completion of the reaction, 10mL of ethyl acetate was added to the reaction mixture to precipitate a solid, which was filtered to obtain by-product 2 (white solid, 68% yield). The filtrate was then washed with saturated brine (5mL × 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to give the crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate = 100)] D 20 =+13.28(c=0.700,CHCl 3 ) The value of the ratio shift R f =0.3 (petroleum ether: ethyl acetate = 50)), by-product 1 (white solid, 100% yield), photocatalyst (yellow solid, 92% yield, reusable). The hydrogen spectrum and the carbon spectrum of the target product are respectively shown in fig. 9 and fig. 10, and the nuclear magnetic resonance spectrum data are respectively as follows: 1 H NMR(400MHz,CDCl 3 )δ:7.22(d,J=8.4Hz,2H),7.11(d,J=8.3Hz,2H),3.59(q,J=7.2Hz,1H),2.32(s,3H),1.46–1.44(m,6H),1.38(s,3H),0.86(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:174.0,138.3,136.4,129.2,127.4,87.1,46.7,38.4,25.1,21.3,20.5,20.3,18.3.
example 3
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by sequentially adding 4-t-butyliodobenzene (78mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6 mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylic acid diethyl ester (75.9mg, 0.1mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol). The reaction flask was capped and sealed, the glove box was removed, and the reaction flask was placed on a stirrer with blue light and allowed to react at room temperature of 25 ℃ for 48 hours. After completion of the reaction, 10mL of ethyl acetate was added to the reaction mixture to precipitate a solid, which was filtered to obtain by-product 2 (white solid, 61% yield). The filtrate was then washed with saturated brine (5mL × 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to give the crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate = 100) to obtain the target product represented by formula IV (21mg, 69% yield, 90% enantiomeric excess percentage, specific optical rotation [ α] D 20 =+11.49(c=0.879,CHCl 3 ) The value of the ratio shift R f =0.5 (petroleum ether: ethyl acetate = 50)), by-product 1 (white solid, 100% yield), photocatalyst (yellow solid, 94% yield, reusable). The hydrogen spectrum and the carbon spectrum of the target product are respectively shown in fig. 11 and fig. 12, and the nuclear magnetic resonance spectrum data are respectively shown in the following steps: 1 H NMR(400MHz,CDCl 3 )δ:7.32(d,J=8.4Hz,2H),7.20(d,J=8.3Hz,2H),3.61(q,J=7.2Hz,1H),1.48–1.46(m,6H),1.39(s,3H),1.30(s,9H),0.84(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:174.1,149.7,138.3,127.2,125.4,87.1,46.6,38.4,34.5,31.4,25.1,20.5,20.3,18.2.
example 4
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by addition of 4-N, N-dimethyliodobenzene (74.1mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (75.9mg, 0.3mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in that order. The reaction flask was capped and sealed, the glove box was removed, and the reaction flask was placed on a stirrer with blue light and allowed to react at room temperature of 25 ℃ for 48 hours. After completion of the reaction, 10mL of ethyl acetate was added to the reaction mixture to precipitate a solid, which was filtered to obtain by-product 2 (white solid, 64% yield). The filtrate was washed with saturated brine (5mLx 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to obtain a crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate = 100) to give the target product represented by formula IV (21mg, 72% yield, 84% enantiomeric excess percentage, specific optical rotation [ α [. Alpha. ]] D 20 =-14.59(c=0.233,CHCl 3 ) Specific shift value R of the product f =0.3 (petroleum ether: ethyl acetate = 20)) by-product 1 (white solid, 100% yield), photocatalyst (yellow solid, 96% yield, reusable). The hydrogen spectrum and the carbon spectrum of the target product are respectively shown in fig. 13 and 14, and the nuclear magnetic resonance spectrum data are respectively shown in the following steps: 1 H NMR(400MHz,CDCl 3 )δ:7.15(d,J=8.4Hz,2H),6.69(d,J=8.3Hz,2H),3.53(q,J=7.2Hz,1H),2.92(s,6H),1.46–1.42(m,6H),1.38(s,3H),0.88(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:174.5,149.7,129.4,128.2,112.9,86.9,46.1,40.8,38.4,25.2,20.6,20.3,18.3.
example 5
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by addition of 4-methoxyiodobenzene (70.2mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6 mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (75.9mg, 0.3mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in that order. The reaction flask was capped and sealed, the glove box was removed, and the reaction flask was placed on a stirrer with blue light and allowed to react at room temperature of 25 ℃ for 48 hours. After completion of the reaction, 10mL of ethyl acetate was added to the reaction mixture to precipitate a solid, which was filtered to obtain by-product 2 (white solid, 62% yield). The filtrate was washed with saturated brine (5mL × 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to obtain a crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate = 100) to give the target product represented by formula IV (14.5mg, 52% yield, 85% enantiomeric excess percentage, specific optical rotation [ α] D 20 =+11.10(c0.838,CHCl 3 ) Specific shift value R of the product f =0.3 (petroleum ether: ethyl acetate = 20)), by-product 1 (white solid, 100% yield), photocatalyst (yellow solid, 94% yield, reusable). The hydrogen spectrum and the carbon spectrum nucleus of the target product are respectively shown in FIG. 15 and FIG. 16, and the magnetic resonance spectrum data are respectively shown in the following steps: 1 H NMR(400MHz,CDCl 3 )δ:7.19(d,J=8.4Hz,2H),6.84(d,J=8.3Hz,2H),3.79(s,3H),3.57(q,J=7.2Hz,1H),1.45–1.43(m,6H),1.38(s,3H),0.86(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:174.1,158.5,133.5,128.5,113.9,87.1,55.3,46.2,38.4,25.1,20.5,20.3,18.3.
example 6
The target compound has the structural formula:
in a glove box filled with argon, the chiral ligand represented by formula III (4.0mg, 0.011mmol) and bis- (1, 5-cyclooctadiene) nickel as nickel (2.8mg, 0.01mmol) were added to 0.5mLN, N-dimethylacetamide, followed by 4-trifluoromethoxyiodobenzene (86.4mg, 0.3mmol), 2-chloropropionic acid (2, 3-trimethyl-2-butyl) ester (20.6mg, 0.1mmol), N, N-dicyclohexylmethylamine (58.5mg, 64. Mu.L, 0.3 mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (75.9mg, 0.3mmol), and 2,4,5, 6-tetrakis (9-carbazolyl) -isophthalonitrile (0.01mmol) in this order. The reaction flask was capped and sealed, the glove box was removed, and the reaction flask was placed on a stirrer with blue light and allowed to react at room temperature of 25 ℃ for 48 hours. After completion of the reaction, 10mL of ethyl acetate was added to the reaction mixture to precipitate a solid, which was filtered to obtain by-product 2 (white solid, 62% yield). The filtrate was washed with saturated brine (5mLx 5), and the organic phase was dried over anhydrous sodium sulfate and then spin-dried to obtain a crude product. The crude product was separated by column chromatography (petroleum ether: ethyl acetate =50: 1) to give the target product represented by formula IV (23.9 mg,72% yield, 86% enantiomeric excess percentage, specific optical rotation [ α] D 20 =+11.87(c0.716,CHCl 3 ) Specific shift value R of the product f =0.3 (petroleum ether: ethyl acetate = 20)), by-product 1 (white solid, 100% yield), photocatalyst (yellow solid, 93% yield, reusable). The hydrogen spectrum and the carbon spectrum of the target product are respectively shown in FIG. 17 and FIG. 18, and the data of the nuclear magnetic resonance spectrum are respectively shown in the following steps: 1 H NMR(400MHz,CDCl 3 )δ:7.28(d,J=8.7Hz,2H),7.15(d,J=8.0Hz,2H),3.64(q,J=7.2Hz,1H),1.47-1.45(m,6H),1.37(s,3H),0.81(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:173.3,148.1,140.1,128.9,121.1,120.5(q,J=257Hz),87.6,46.4,38.4,25.0,20.5,20.3,18.1.
referring to the method in example 1, a series of (S) -2-aryl propionate compounds are synthesized respectively by changing the reaction substrate and keeping other raw materials, conditions and operations unchanged, and the yield and the enantiomeric excess percentage can reach more than a medium level. The derivatives synthesized are shown in the following table in particular in examples 7 to 41. The substituents in table 1 are those shown in the following structural formulae.
TABLE 1
Wherein the hydrogen spectra and carbon spectra of the target products of the above examples 19, 23 and 26 are shown in fig. 19 and 20, fig. 21 and 22, and fig. 23 and 24, respectively, and the nmr data are shown in fig. 1:
1 H NMR(400MHz,CDCl 3 )δ:7.34–7.25(m,3H),7.11–7.07(m,1H),7.02–6.92(m,3H),6.89–6.86(m,1H),3.60(q,J=7.2Hz,1H),1.45-1.43(m,6H),1.38(s,3H),0.83(s,9H).
13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:173.4,157.4,143.5,129.82,129.80,123.3,122.6,118.9,118.2,117.4,87.4,47.0,38.4,25.1,20.5,20.3,18.1.
1 H NMR(400MHz,CDCl 3 )δ:7.34–7.25(m,3H),7.11–7.00(m,1H),7.00–6.93(m,3H),6.89–6.86(m,1H),3.60(q,J=7.2Hz,1H),1.45–1.43(m,6H),1.38(s,3H),0.83(s,9H).
13 C{ 1 H}NMR(101MHz,CDCl 3 )δ:173.2,159.8(d,J=249.3Hz),142.7(d,J=7.6Hz),135.7,130.7(d,J=3.9Hz),129.0(d,J=2.8Hz),128.5,127.7,127.5(d,J=13.6Hz),123.7(d,J=3.2Hz),115.3(d,J=23.6Hz),87.7,46.6,38.5,25.1,20.6,20.4,18.1.
1 H NMR(400MHz,CDCl 3 )δ7.71–7.65(m,3H),7.40–7.38(m,1H),7.15–7.11(m,2H),3.91(s,3H),3.76(q,J=7.2Hz,1H),1.54(d,J=7.2Hz,3H),1.47(s,3H),1.38(s,3H),0.84(s,9H);
13 C NMR(101MHz,CDCl 3 )δ:174.0,157.6,136.5,133.6,129.3,129.1,127.0,126.5,126.0,118.9,105.7,87.3,55.4,47.0,38.4,25.1,20.6,20.3,18.3.
example 42
In example 1, 0.5mL of N, N-dimethylacetamide was replaced with 0.5mL of acetonitrile, bis- (1, 5-cyclooctadiene) nickel (2.8mg, 0.01mmol) was replaced with nickel chloride (2.4mg, 0.02mmol), the amount of chiral nitrogen ligand represented by formula III was increased to (8mg, 0.02mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (65mg, 3.0eq.) was replaced with triethylamine (50.5mg, 5.0eq.), and N, N-dicyclohexylmethylamine (65uL, 3.0eq.) was replaced with cesium carbonate (162mg, 5.0eq.)
Meanwhile, the reaction time was changed to 12 hours, the reaction temperature was changed to 10 ℃, and other conditions, materials and operations were kept unchanged, to finally obtain the pure target product (oily liquid, 11.1mg,30% yield, 90% enantiomeric excess). Specific shift value R of the product f =0.54 (petroleum ether: ethyl acetate = 50) and the product hydrogen spectrum and carbon spectrum are respectively in fig. 25 and 26, and the spectrum data are respectively: 1 H NMR(400MHz,CDCl 3 )δ:7.32-7.19(m,5H),3.61(q,J=7.2Hz,1H),1.47–1.46(m,6H),1.37(s,3H),0.82(s,9H). 13 C{ 1 H}NMR(101MHz,CDCl 3 ) Delta 173.8,141.4,128.5,127.6,126.9,87.2,47.1,38.4,25.1,20.6,20.2,18.2. The obtained by-product 2 (white solid, 66% yield) was recovered; the resulting byproduct 1 (white solid, 100% yield) was recovered; the photocatalyst was recovered (yellow solid, 96% yield, reusable).
Example 43
2,4,5, 6-tetra (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in example 1 was replaced with: 4,4' -di-tert-butyl-2, 2' -bipyridine) bis [ (2-pyridyl) phenyl ] iridium (III) hexafluorophosphate (9.1mg, 0.01mmol), 0.5mL of N, N-dimethylacetamide was replaced with an equal volume of DMSO, bis- (1, 5-cyclooctadiene) nickel (2.8mg, 0.01mmol) was replaced with (1, 1' -bis (diphenylphosphino) ferrocene) nickel dichloride (27.2mg, 0.04mmol), the amount of chiral nitrogen ligand was increased to (16mg, 0.04mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (65mg, 3.0eq.) was replaced with N, N-dicyclohexylmethylamine (65uL, 3.0eq.), N, N-dicyclohexylmethylamine (65uL, 3.0eq.) was replaced with sodium carbonate (52.5mg, 5.0eq.)
The reaction time was changed to 96 hours, the reaction temperature was changed to 50 ℃, and other conditions, materials and operations were kept constant to obtain a pure product (oily liquid, 6.2mg,25% yield, 90% enantiomeric excess). Specific shift value R of the product f =0.54 (petroleum ether: ethyl acetate = 50; the resulting byproduct 2 (white solid, 66% yield) was recovered; the obtained by-product 1 (white solid, 100% yield) was recovered.
Example 44
2,4,5, 6-tetra (9-carbazolyl) -isophthalonitrile (8mg, 0.01mmol) in example 1 was replaced with: tris (2, 2' -bipyrazinyl) ruthenium bis (hydrochloride) salt (7.5mg, 0.01mmol), 0.5ml N, N-dimethylacetamide was replaced with an equivalent volume of DMF, bis- (1, 5-cyclooctadiene) nickel (2.8mg, 0.01mmol) was replaced with bis (triphenylphosphine) nickel chloride (65.4mg, 0.1mmol), the amount of chiral nitrogen ligand was increased to (40mg, 0.1mmol), diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (65mg, 3.0eq.) was replaced with di-tert-butyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate (154.5mg, 5.0eq.), and N, N-dicyclohexylmethylamine was increased to (109ul, 5.0eq.)
The reaction time was changed to 48 hours, and the reaction temperature was changedAt 25 ℃ the conditions, materials and operations were kept constant to obtain the pure product (oily liquid, 18.6mg,75% yield, 90% enantiomeric excess). Specific shift value R of the product f =0.54 (petroleum ether: ethyl acetate = 50; the obtained by-product 2 (white solid, 66% yield) was recovered; the obtained by-product 1 (white solid, 100% yield) was recovered.
Claims (2)
1. A synthesis method of (S) -2-aryl propionate compounds is characterized in that under the condition of blue light with the wavelength of 400nm, a compound shown in a formula I and a compound shown in a formula II are used as raw materials, under the condition of a chiral ligand shown in a formula III, a nickel-based catalyst, a photocatalyst, a reducing agent and alkali, in any one or more solvents selected from dimethyl sulfoxide, N-dimethylformamide, N-dimethylacetamide and acetonitrile, the reaction temperature is 10-50 ℃, and the (S) -2-aryl propionate compounds shown in a formula IV are obtained through reaction in a nitrogen atmosphere:the nickel catalyst is selected from one or more of nickel chloride, nickel bromide, nickel iodide, bis- (1, 5-cyclooctadiene) nickel, nickel bromide (II) diethylene glycol dimethyl ether compound, nickel diacetone, bis (triphenylphosphine) nickel chloride, (1, 1' -bis (diphenylphosphino) ferrocene) nickel dichloride or nickel chloride dimethoxyethane compound;
the photocatalyst is selected from one or more of tris (2, 2 '-bipyrazine) ruthenium di (hydrochloride), bis [ (2-pyridyl) phenyl ] iridium (III) hexafluorophosphate of 4,4' -di-tert-butyl-2, 2 '-bipyridine), iridium (tris (2-phenylpyridine), bis [2- (4-fluorophenyl) pyridine ] iridium (III) hexafluorophosphate of 2,2' -bipyridine or 2,4,5, 6-tetra (9-carbazolyl) -isophthalonitrile;
the reducing agent is selected from one or more of diethyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate, di-tert-butyl 2, 6-dimethyl-1, 4-dihydropyridine-3, 5-dicarboxylate and dimethyl 1, 4-dihydro-2, 6-dimethylpyridine-3, 5-dicarboxylate;
the alkali is selected from one or more of N, N-dicyclohexyl methylamine, triethylamine, N-diisopropyl ethylamine, cesium carbonate, sodium carbonate, lithium carbonate or potassium carbonate;
the molar ratio of the compound shown in the formula I to the compound shown in the formula II, the nickel-based catalyst, the chiral ligand shown in the formula III, the photocatalyst, the reducing agent and the alkali is 1:3:0.1:0.11:0.1:3:3;
R 1 optionally, the compound is selected from branched chain and straight chain alkyl with 1 to 10 carbon atoms, alkyl with 1 to 10 carbon atoms containing ether bonds, cycloalkyl with 3 to 6 carbon atoms, benzyl or 4-substituted benzyl, wherein the substituent in the 4-substituted benzyl is selected from trifluoromethyl, halogen or alkoxy with 1 to 10 carbon atoms;
R 2 optionally branched and straight chain alkyl of 1 to 10 carbon atoms, benzyl;
ar is optionally selected from phenyl, mono-or poly-substituted phenyl, naphthyl, substituted naphthyl, pyridyl, substituted pyridyl, indolyl, N-substituted indolyl, benzofuranyl, fluorene or thienyl;
the substituent in the 'mono-substituted or multi-substituted phenyl' is selected from branched chain and straight chain alkyl with 1 to 10 carbon atoms, N, -dimethylamino, alkoxy with 1 to 10 carbon atoms, trifluoromethoxy, halogen, trifluoromethyl, acetyl, ester group, cyano, boron ester group, phenol group, phenyl or pyrrole group;
the substituent in the substituted pyridyl is selected from halogen;
the substituent in the N-substituted indolyl is selected from alkyl with 1 to 10 carbon atoms;
the substituent in the substituted naphthyl is selected from alkoxy with 1 to 10 carbon atoms.
2. The method of claim 1, wherein R in formula I 1 Selected from branched or straight chain alkyl with 1 to 4 carbon atoms, alkyl with 1 to 4 carbon atoms containing ether bond, cycloalkyl with 3 to 6 carbon atoms, benzyl and 4-substituted benzyl, wherein the substituent in the 4-substituted benzyl is selected from trifluoromethyl, halogen or alkoxy with 1 to 3 carbon atoms(ii) a And/or
R in the formula I 2 Optionally selected from branched and linear alkyl of 1 to 7 carbon atoms, benzyl; and/or
Ar in the formula II is selected from phenyl, 4-methylphenyl, 4-tert-butylphenyl, 4-N, N-dimethylphenyl, 4-methoxyphenyl, 4-trifluoromethoxyphenyl, 4-fluorophenyl, 4-chlorophenyl, acetylphenyl, 4-ethoxycarbonylphenyl, 4-cyanophenyl, 4-borocarbonylphenyl, 3-methylphenyl, 3-phenylphenyl, 3-chlorophenyl, 2-methylphenyl, 4-biphenyl, 3-fluoro-4-biphenyl, 4-pyrrolophenyl, 2-9H-fluorenyl, 1-naphthyl, 5-N-methylindolyl, 3-thienyl or 3-benzofuranyl.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911357726 | 2019-12-25 | ||
CN201911357726X | 2019-12-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111454150A CN111454150A (en) | 2020-07-28 |
CN111454150B true CN111454150B (en) | 2023-03-28 |
Family
ID=71673427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010190577.9A Active CN111454150B (en) | 2019-12-25 | 2020-03-18 | Synthesis method of (S) -2-aryl propionate compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111454150B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113908883B (en) * | 2021-10-13 | 2023-08-29 | 安徽美致诚药业有限公司 | Synthesis method of 1- (4-methoxyphenyl) acetone |
CN114315957B (en) * | 2021-12-30 | 2023-07-07 | 深圳瑞德林生物技术有限公司 | Preparation method of polypeptide |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008071736A1 (en) * | 2006-12-15 | 2008-06-19 | Glaxo Group Limited | Benzamide derivatives as ep4 receptor agonists |
CN103012144A (en) * | 2012-12-26 | 2013-04-03 | 哈药集团技术中心 | Preparation method of flurbiprofen axetil |
CN105017211A (en) * | 2014-04-30 | 2015-11-04 | 重庆华邦制药有限公司 | 2-phenyl propionic ester derivative and preparation method and application thereof |
CN109232386A (en) * | 2018-11-12 | 2019-01-18 | 中国农业大学 | A kind of method of asymmetric syntheses (S)-preclamol |
-
2020
- 2020-03-18 CN CN202010190577.9A patent/CN111454150B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008071736A1 (en) * | 2006-12-15 | 2008-06-19 | Glaxo Group Limited | Benzamide derivatives as ep4 receptor agonists |
CN103012144A (en) * | 2012-12-26 | 2013-04-03 | 哈药集团技术中心 | Preparation method of flurbiprofen axetil |
CN105017211A (en) * | 2014-04-30 | 2015-11-04 | 重庆华邦制药有限公司 | 2-phenyl propionic ester derivative and preparation method and application thereof |
CN109232386A (en) * | 2018-11-12 | 2019-01-18 | 中国农业大学 | A kind of method of asymmetric syntheses (S)-preclamol |
Non-Patent Citations (2)
Title |
---|
(S)-(+)氟比洛芬的合成;王尊元等;《中国现代应用药学杂志》;20061231;第23卷(第6期);第463-465页 * |
Nickel-Catalyzed Direct Electrochemical Cross-Coupling between Aryl Halides and Activated Alkyl Halides;Muriel Durandetti,et al.,;《J.Org.Chem.》;19961231;第61卷(第5期);第1748-1755页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111454150A (en) | 2020-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1894266B (en) | Process for the preparation of heteroleptic, ortho-metallated organometallic compounds | |
US7250510B2 (en) | Transition metal complexes of N-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
CN111454150B (en) | Synthesis method of (S) -2-aryl propionate compound | |
CN112940036B (en) | Preparation method of benzothiazole phosphate compound | |
CN111925356B (en) | Synthesis method and application of chiral quinoline-imidazoline ligand | |
WO2018168815A1 (en) | METHOD FOR PRODUCING 3, 6-DISUBSTITUTED IMIDAZO[1, 2-b]PYRIDAZINE DERIVATIVE | |
JP6552427B2 (en) | Ruthenium-based complexes | |
CN110183400B (en) | Visible light induced polyfluoroalkylated aldehyde hydrazone derivative and synthesis method thereof | |
CN111285881B (en) | Thieno [3,4-b ] indole derivative and synthetic method thereof | |
CN109810147B (en) | Pyrene-labeled benzimidazole nitrogen heterocyclic carbene palladium metal complex, and preparation and application thereof | |
CA2556850A1 (en) | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
CN111057080B (en) | Preparation method of boron-containing indolinone derivative | |
CN112939891B (en) | Method for preparing biphenyl benzothiazole compound | |
JP4360096B2 (en) | Optically active quaternary ammonium salt, method for producing the same, and method for producing optically active α-amino acid derivative using the same as phase transfer catalyst | |
CN114591217A (en) | Process for the preparation of 6, 6-dimethyl-3-azabicyclo- [3.1.0] -hexane and lactone intermediates thereof | |
JP2008162976A (en) | Method for synthesizing spacer-introduced bis(terpyridine) compound | |
CN110746253B (en) | Synthesis method of beta, beta-disubstituted propionate derivative | |
JP4413507B2 (en) | Pincer metal complex, method for producing the same, and pincer metal complex catalyst | |
CN109912640A (en) | A kind of preparation method of 2-Pyrrolidone class compound | |
CA2551412A1 (en) | Transition metal complexes of n-heterocyclic carbenes, method of preparation and use in transition metal catalyzed organic transformations | |
JP2003277333A (en) | Method for producing halotriarylamines and method for producing vinyltriarylamines using the same | |
JPWO2005070876A1 (en) | Enantioselective method of nucleophilic addition reaction of enamide to imine and synthesis method of α-amino-γ-keto acid ester | |
JP5594821B2 (en) | Novel azacalix [3] pyridine and process for producing the same | |
CN110015942B (en) | Method for directly synthesizing biaryl compound without metal catalysis | |
CN116396315A (en) | Synthesis method of 1, 4-dihydronaphthalene structure compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |